Skip to main content

MoneyWorks4Me

Zydus Lifesciences informs about press release

19 Apr 2023 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated April 19, 2023 titled ‘Zydus receives final approval from the USFDA for Roflumilast Tablets, 250 mcg’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1905.00
Dr. Reddys Labs. 1385.00
Cipla 1406.00
Lupin 2012.00
Zydus Lifesciences 1213.05
View more..